Pathophysiology of immune thrombocytopenia

Current Opinion in Hematology
June LiHeyu Ni

Abstract

Immune thrombocytopenia (ITP) is a common autoimmune bleeding disorder with as of yet, no established clinical prognostic or diagnostic biomarkers. Patients frequently experience a markedly decreased quality of life and may be at risk for severe/fatal haemorrhage. Here, we address discoveries in the pathogenesis of ITP, and novel therapeutic strategies in mouse models and human patients. Consolidation of these findings should be important in providing insight to establish future prognostic protocols as well as cutting-edge therapeutics to target refractory ITP. It is unknown why a significant portion of ITP patients are refractory to standard treatments. Recent findings suggest distinct heterogeneity in ITP including antibody-mediated platelet activation, Fc-independent desialylated platelet clearance, attenuation of platelet-mediated hepatic thrombopoietin generation, and decreased CD8 T-suppressor generation. These mechanisms may partially explain clinical observations of increased refractoriness to standard therapies targeting classical Fc-dependent pathways. Moreover, these have initiated investigations into platelet desialylation as a diagnostic/prognostic marker and therapeutic target. Recent evidence of distinct ITP path...Continue Reading

Citations

Sep 21, 2019·Veterinary Clinical Pathology·Dana N LeVine, Marjory B Brooks
Dec 24, 2019·Journal of Thrombosis and Haemostasis : JTH·Shiying Silvia ZhengBeng Hock Chong
May 28, 2019·Science and Engineering Ethics·Nishakanthi GopalanMohd Salim Mohamed
Jun 24, 2020·Journal of Thrombosis and Haemostasis : JTH·Madeleine L StimpsonCharlotte A Bradbury
Apr 30, 2020·International Journal of Molecular Sciences·Alexey A MartyanovAnd Anastasia N Sveshnikova
Jun 10, 2020·Clinical and Experimental Immunology·R CastelliL Bergamaschini
Aug 28, 2020·Frontiers in Immunology·Conglei LiHeyu Ni
Mar 12, 2020·Blood·Yosuke MorodomiTaisuke Kanaji
Jun 20, 2020·Blood·Karin M Hoffmeister
Dec 22, 2020·Hämostaseologie·Karina AlthausTamam Bakchoul
Mar 17, 2021·Experimental Hematology & Oncology·Yuwen ChenYingyu Chen
Apr 3, 2021·Therapeutic Advances in Hematology·Nikki Agarwal, Ankit Mangla
Jan 19, 2021·BJA Education·R AgarwalaJ P Campbell
May 2, 2021·Scientific Reports·Anastasia A IgnatovaMikhail A Panteleev
May 13, 2021·Research and Practice in Thrombosis and Haemostasis·Danielle KarakasHeyu Ni
Jul 31, 2021·Journal of Clinical Laboratory Analysis·Ting WangZonghong Shao
Sep 2, 2021·The New England Journal of Medicine·Paula H B Bolton-Maggs, James N George
Sep 10, 2021·Epigenomics·Abdollah JafarzadehHamid Reza Mirzaei
Oct 10, 2021·International Journal of Hematology·Junichi KitazawaUNKNOWN Platelet Committee of the Japanese Society of Pediatric Hematology/Oncology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.